Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippo de Braud

Showing results (181-190 of 497) with videos related to

Pageof 50
Sort By:
Endocrine-Related Cancer|July 20, 2007
Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter StudyMaria Chiara Zatelli, Mirella Torta, Antonette Leon, et al.
Expert Review of Anticancer Therapy|June 30, 2016
Update on medical treatment of small intestinal neuroendocrine tumorsSara Pusceddu, Daniela Femia, Giuseppe Lo Russo, et al.
Clinical Lung Cancer|September 21, 2025
Refining High-Risk EGFR-Mutant Lung Cancer Patients: The Role of Adjusted Variant Allele Frequency in First-Line Osimertinib TherapyMarta Brambilla, Francesca Barbetta, Giuseppe Nardo, et al.
Frontiers in Oncology|September 5, 2022
Case Report: Prolonged clinical benefit with sequential trastuzumab-containing treatments in a patient with advanced extramammary Paget disease of the groinEmma Zattarin, Federico Nichetti, Francesca Ligorio, et al.
Cancer Treatment Reviews|November 27, 2018
Targeting the PI3K/AKT/mTOR pathway in biliary tract cancers: A review of current evidences and future perspectivesFrancesca Corti, Federico Nichetti, Alessandra Raimondi, et al.
World Journal of Clinical Cases|December 18, 2014
Role of MGMT as biomarker in colorectal cancerAlessandro Inno, Giuseppe Fanetti, Maria Di Bartolomeo, et al.
The Breast Journal|February 28, 2019
Single Institution trial of anthracycline- and taxane-based chemotherapy for operable breast cancer: The ASTER studyGabriella Mariani, Giulia Galli, Stefano Cavalieri, et al.
Cancers|January 11, 2024
Comparative Effectiveness of First-Line Selpercatinib versus Standard Therapies in Patients with RET-Activated Cancers: An Exploratory Interpatient Analysis of LIBRETTO-001Filippo De Braud, Barbara Deschler-Baier, John C Morris, et al.
Tumori|May 2, 2018
Entering the third decade of experience with octreotide LAR in neuroendocrine tumors: A review of current knowledgeSara Pusceddu, Natalie Prinzi, Alessandra Raimondi, et al.
Critical Reviews in Oncology/Hematology|February 28, 2012
Vaccines in non-small cell lung cancer: rationale, combination strategies and update on clinical trialsTommaso De Pas, Monica Giovannini, Maria Rescigno, et al.
Pageof 50

Showing results (181-190 of 497) with videos related to

Sort By:
Pageof 50
Endocrine-Related Cancer|July 20, 2007
Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter StudyMaria Chiara Zatelli, Mirella Torta, Antonette Leon, et al.
Expert Review of Anticancer Therapy|June 30, 2016
Update on medical treatment of small intestinal neuroendocrine tumorsSara Pusceddu, Daniela Femia, Giuseppe Lo Russo, et al.
Clinical Lung Cancer|September 21, 2025
Refining High-Risk EGFR-Mutant Lung Cancer Patients: The Role of Adjusted Variant Allele Frequency in First-Line Osimertinib TherapyMarta Brambilla, Francesca Barbetta, Giuseppe Nardo, et al.
Frontiers in Oncology|September 5, 2022
Case Report: Prolonged clinical benefit with sequential trastuzumab-containing treatments in a patient with advanced extramammary Paget disease of the groinEmma Zattarin, Federico Nichetti, Francesca Ligorio, et al.
Cancer Treatment Reviews|November 27, 2018
Targeting the PI3K/AKT/mTOR pathway in biliary tract cancers: A review of current evidences and future perspectivesFrancesca Corti, Federico Nichetti, Alessandra Raimondi, et al.
World Journal of Clinical Cases|December 18, 2014
Role of MGMT as biomarker in colorectal cancerAlessandro Inno, Giuseppe Fanetti, Maria Di Bartolomeo, et al.
The Breast Journal|February 28, 2019
Single Institution trial of anthracycline- and taxane-based chemotherapy for operable breast cancer: The ASTER studyGabriella Mariani, Giulia Galli, Stefano Cavalieri, et al.
Cancers|January 11, 2024
Comparative Effectiveness of First-Line Selpercatinib versus Standard Therapies in Patients with RET-Activated Cancers: An Exploratory Interpatient Analysis of LIBRETTO-001Filippo De Braud, Barbara Deschler-Baier, John C Morris, et al.
Tumori|May 2, 2018
Entering the third decade of experience with octreotide LAR in neuroendocrine tumors: A review of current knowledgeSara Pusceddu, Natalie Prinzi, Alessandra Raimondi, et al.
Critical Reviews in Oncology/Hematology|February 28, 2012
Vaccines in non-small cell lung cancer: rationale, combination strategies and update on clinical trialsTommaso De Pas, Monica Giovannini, Maria Rescigno, et al.
Pageof 50